Researchers at the University of Maryland School of Medicine’s Center for Vaccine Development and Global Health (CVD) have completed a successful Phase I clinical trial of a novel vaccine designed to protect against both typhoid fever and invasive non-typhoidal Salmonella – two leading causes of illness and death in children in sub-Saharan Africa.
Please follow and like us:
